Back
Novo Nordisk A/S Vs. AstraZeneca PLC Industry Stock Comparison
Sell
30
NVO
Novo Nordisk A/S
Last Price:
$52.00
Seasonality Move:
3.8%
Buy
58
AZN
AstraZeneca PLC
Last Price:
$91.70
Seasonality Move:
1.97%
Sell
30
Novo Nordisk A/S (NVO)
is a Sell
Is Novo Nordisk A/S a Buy, Sell or Hold?
-
The current Novo Nordisk A/S [NVO] share price is $50.88. The Score for NVO is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
-
NVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
58
AstraZeneca PLC (AZN)
is a Buy
Is AstraZeneca PLC a Buy, Sell or Hold?
-
The current AstraZeneca PLC [AZN] share price is $91.93. The Score for AZN is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
-
AZN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NVO Stock Price Chart
What is Novo Nordisk A/S's stock price today?
-
The Novo Nordisk A/S share price today is $50.88Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NVO is experiencing slight selling pressure.
AZN Stock Price Chart
What is AstraZeneca PLC's stock price today?
-
The AstraZeneca PLC share price today is $91.93The current trend is moderately bullish and AZN is experiencing selling pressure, which indicates risk of future bearish movement.
NVO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.61 | Buy |
| Relative Strength Index (14 RSI): | 54.93 | Buy |
| Chaikin Money Flow: | -691238 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (47.35 - 50.89) | Buy |
| Bollinger Bands (100): | (48.5 - 57) | Sell |
AZN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.98 | Buy |
| Relative Strength Index (14 RSI): | 56.38 | Buy |
| Chaikin Money Flow: | -2022414 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (90.27 - 92.49) | Buy |
| Bollinger Bands (100): | (78.93 - 89.89) | Buy |
NVO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 50.79 | Buy |
| 20-day SMA: | 49.36 | Buy |
| 50-day SMA: | 49.28 | Buy |
| 200-day SMA: | 59.91 | Sell |
| 8-day EMA: | 50.8 | Buy |
| 20-day EMA: | 49.9 | Buy |
| 50-day EMA: | 50.46 | Buy |
| 200-day EMA: | 62.29 | Sell |
AZN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 92.17 | Sell |
| 20-day SMA: | 91.23 | Buy |
| 50-day SMA: | 88.52 | Buy |
| 200-day SMA: | 77.72 | Buy |
| 8-day EMA: | 92.05 | Sell |
| 20-day EMA: | 91.29 | Buy |
| 50-day EMA: | 88.77 | Buy |
| 200-day EMA: | 80.61 | Buy |
Novo Nordisk A/S Earnings Growth & NVO Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.45 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.18 per share, and an increase next year of $0.37 per share.
AstraZeneca PLC Earnings Growth & AZN Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.56 per share, and an increase next year of $0.66 per share.
Novo Nordisk A/S Technical Analysis
| Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
AstraZeneca PLC Technical Analysis
| Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||